CODX vs SNPS · rev $3.9M vs P/E 63, rev $7.05B
Co-Diagnostics, Inc. Common Stock (CODX) versus Synopsys Inc (SNPS) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Synopsys Inc (SNPS) is a software - infrastructure company listed on US.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported SNPS revenue for 2025-10-31 was $7.05B. Net income was $1.33B. Revenue was up 15.1% from 2024-10-31 to 2025-10-31. SNPS currently screens at market cap $85.14B and trailing P/E 63.3.
CODX currently screens at market cap $31.4M. SNPS currently screens at market cap $85.14B and trailing P/E 63.3.
Not investment advice. Open the CODX and SNPS stock pages for the full models.
Not investment advice.